Scholarlink

<p>This study aimed to investigate the relationship between <i>GRM7</i> polymorphisms and the levels of glutamate (Glu) and glutathione (GSH) in bilateral auditory regions (ARs) of ARHL patients. Seventy-eight ARHL patients (mean age, 65.94&#xa0;years ± 3.37 [SD]; 44 men) and 46 normal hearing (NH) controls (mean age, 65.72&#xa0;years ± 2.32 [SD]; 28 men) were enrolled. Glu and GSH levels in bilateral ARs of all participants were measured and estimated by using magnetic resonance spectroscopy (MRS) and LCModel. In addition, we collected peripheral venous blood samples from all participants for DNA extraction and investigated polymorphisms in the <i>GRM7</i> gene using TaqMan SNP genotyping. The results showed that Glu and GSH levels in bilateral ARs were significantly lower in <i>GRM7</i> high-risk group compared with <i>GRM7</i> low-risk group, regardless of disease status (all <i>p</i><sub>glu</sub> &lt; 0.001; all <i>p</i><sub>gsh</sub> = 0.001). Furthermore, <i>GRM7</i> low-risk ARHL group had lower Glu levels in bilateral ARs than <i>GRM7</i> low-risk NH group, whereas no difference was observed between NH and ARHL groups in high-risk (all <i>p</i><sub>glu</sub> &lt; 0.05; all <i>p</i><sub>glu</sub> &gt; 0.05). Finally, we found that Glu and GSH levels were positively correlated only in the low-risk NH group (<i>r</i><sub>left</sub> = 0.536 <i>p</i> = 0.007; <i>r</i><sub>right</sub> = 0.545 <i>p</i> = 0.006). The glutamatergic dysfunction in ARs may be associated with <i>GRM7</i> polymorphisms, and redox reactions are involved in regulating the glutamatergic abnormalities. The TT genotype of <i>GRM7</i> rs11928865 SNP is more vulnerable to damage from the antioxidant and the glutamatergic system.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association of GRM7 Polymorphisms with Bilateral Auditory Regions Glutamate and Coupling with Glutathione in ARHL Patients

  • 期刊论文

  • 发表日期：

    2025年5月13日

查看全文
  • Jing Wang,
  • Fuyan Li,
  • Fuxin Ren,
  • Wen Ma,
  • Yuxi Liu,
  • Wenjing Zhang,
  • Xi Li,
  • Yanfei Bi,
  • Qian Xin,
  • Fei Gao

摘要

This study aimed to investigate the relationship between GRM7 polymorphisms and the levels of glutamate (Glu) and glutathione (GSH) in bilateral auditory regions (ARs) of ARHL patients. Seventy-eight ARHL patients (mean age, 65.94 years ± 3.37 [SD]; 44 men) and 46 normal hearing (NH) controls (mean age, 65.72 years ± 2.32 [SD]; 28 men) were enrolled. Glu and GSH levels in bilateral ARs of all participants were measured and estimated by using magnetic resonance spectroscopy (MRS) and LCModel. In addition, we collected peripheral venous blood samples from all participants for DNA extraction and investigated polymorphisms in the GRM7 gene using TaqMan SNP genotyping. The results showed that Glu and GSH levels in bilateral ARs were significantly lower in GRM7 high-risk group compared with GRM7 low-risk group, regardless of disease status (all pglu < 0.001; all pgsh = 0.001). Furthermore, GRM7 low-risk ARHL group had lower Glu levels in bilateral ARs than GRM7 low-risk NH group, whereas no difference was observed between NH and ARHL groups in high-risk (all pglu < 0.05; all pglu > 0.05). Finally, we found that Glu and GSH levels were positively correlated only in the low-risk NH group (rleft = 0.536 p = 0.007; rright = 0.545 p = 0.006). The glutamatergic dysfunction in ARs may be associated with GRM7 polymorphisms, and redox reactions are involved in regulating the glutamatergic abnormalities. The TT genotype of GRM7 rs11928865 SNP is more vulnerable to damage from the antioxidant and the glutamatergic system.